Enzo, Yale Sue Applera for Infringing Sequencing Reagent Patents

NEW YORK, June 8 (GenomeWeb News) - Enzo Biochem today said that it has filed suit against Applera for infringing patented technologies related to DNA sequencing systems.

The suit, filed in the US District Court for the District of Connecticut against Applera and its Tropix subsidiary, charges the firms with infringing US Patent Nos. 5,476,928; 5,449,767; 5,328,824; 4,711,955; 5,082,830; and 4,994,373. Four of these patents are exclusively licensed to Enzo by YaleUniversity, which is also a named as a plaintiff in the suit. The remaining patents are owned by Enzo Biochem's subsidiary, Enzo Life Sciences.

The patent suite covers compounds used in DNA sequencing systems. In a statement, Enzo said that Applera and Tropix "improperly make, use and sell the patented products and technologies, as well as providing others with unauthorized and prohibited access to the patented products and technologies."

Enzo and Yale are seeking "injunctive relief and monetary damages."